Stockreport

Erasca Shares Plunge 48% After Trial Patient Death, Patent Dispute Emerges [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF cancer-drug developer disclosed a patient death linked to severe side effects in its clinical trial, a development that could complicate the company's broader safety nar [Read more]